概括
囊性纤维化患者经常出现肝病,包括肝硬化和水出血. 应该避免服用阿司匹林,注射性硬化疗法可能更好地用于控制囊性纤维化肝病中的出血.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 肝病学 肝病学是一种肝病学.
- 肺部病理学 肺部病理学
背景情况:
- 囊性纤维化 (CF) 是一种多系统遗传疾病.
- 肝脏参与是CF患者的重要并发症.
- 肝脏表现的范围从异常的肝功能测试到肝硬化.
研究的目的:
- 为了前性地评估儿科囊性纤维化患者的肝脏参与.
- 评估CF肝病的发病率和进展情况.
- 确定CF中水出血的最佳管理策略.
主要方法:
- 74名CF患者 (1-19岁) 的前性观察性研究,持续时间为1-7年.
- 评估包括肝功能测试,肝硬化成像检查,并监测诸如水出血和缩症等并发症.
- 治疗水出血的治疗结果 (转移手术与注射硬化疗法) 被比较.
主要成果:
- 20名患者出现肝脏问题,18名患者出现肝硬化 (年龄为4至13岁).
- 6名患者出现了出血,其中50%与阿司匹林使用有关;建议避免服用阿司匹林.
- 注射性硬化疗法证明了疗效和更好的耐受性,与分流手术相比,用于控制水出血.
结论:
- 肝病,包括肝硬化和水出血,是囊性纤维化病的常见和严重并发症.
- 在CF患者中,应严格避免服用阿司匹林,因为可能导致水出血的风险.
- 注射性硬化疗法代表了一种有前途且耐受良好的替代方案,用于控制CF的水出血,可能会超过传统的分流手术.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
相关概念视频
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
